Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

Background: De novo steatosis is the main criteria for non-alcoholic fatty liver disease (NAFLD), which is becoming a clinically relevant comorbidity in HIV-infected patients. This may be due to the HIV virus itself, as well as long-term toxicities deriving from antiretroviral therapy. Therefore, HI...

Full description

Bibliographic Details
Main Authors: Jenny Bischoff, Wenyi Gu, Carolynne Schwarze-Zander, Christoph Boesecke, Jan-Christian Wasmuth, Kathrin van Bremen, Leona Dold, Jürgen K Rockstroh, Jonel Trebicka
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:EClinicalMedicine
Subjects:
Hiv
Cap
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537021003965